United States · FDA National Drug Code directory
CLIGAVYX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83831-159_29f2a48e-b9af-486e-bc0c-eab3a1ce0b3c
- Product NDC
- 83831-159
- Form
- INJECTION
- Composition / generic term
- fulvestrant
- Labeler
- Avyxa Pharma, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260701
- Source listing expiry
- 20271231
Source-listed ingredients
- FULVESTRANT — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, GLASS in 1 CARTON (83831-159-02) / 5 mL in 1 SYRINGE, GLASS · 83831-159-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →